This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
This article presents Ways To Enhance Your Budgeting Strategy with incremental tweaks, monitoring, and alignment to goals.
21,926 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Memory prices and AI data demands have put Micron and Sandisk in the spotlight. This piece breaks down what’s driving...
Two early leaders in the electric air taxi race collide with a policy signal that could tilt the field. This analysis...
A sharp one-week move in a space stock can redefine risk and opportunity. This guide explains why rocket stock skyroc...
A notable shift is underway in agribusiness investing. Funds are placing sizable bets on agriculture stocks, signalin...
Ciena’s shares jumped sharply in the first half of 2026. This article dives into the AI-driven demand for optical net...
The launch of oral Wegovy marked a turning point for weight-loss drugs and stock investors. But a newer, rival oral G...
Investors chasing SpaceX-style wins without a private bet must weigh public players carefully. This guide compares AS...
Investors piled into Nextpower after strong 2026 results and a strategic acquisition. This article breaks down the ca...
A Wall Street titan is backing Crypto.com with a substantial investment, signaling a new era of cross-market liquidit...
As AI infrastructure expands, CoreWeave sits at a pivotal point. This guide identifies three key risks investors shou...
A senior comms exec says AI notetakers are moving from convenience to liability as governance gaps and confidential n...